Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Authors

Alessandra Bettiol, Federica Bello, Ruggero Mazzotta, Irene Mattioli, Giacomo Bagni, Edoardo Biancalana, Maria Canfora, Mariapaola Lisi, Danilo Malandrino, Miki Palmerini, Maurizio Pieroni, Maria Romanelli, Maria Letizia Urban, Savino Sciascia, Domenico Prisco, Elena Silvestri, Iacopo Olivotto, Giacomo Emmi

Published in

Rheumatology (Oxford, England). Jul 02, 2026. Epub Jul 02, 2026.

Abstract

To characterize prevalence, patterns, and clinical correlates of cardiac involvement in a cohort of patients with Behçet's syndrome (BS) undergoing clinically-driven cardiological assessment.
This retrospective study included adult patients with BS, followed at a tertiary referral center (Florence, Italy), who underwent clinically-driven cardiological evaluation. Clinical, demographic, and therapeutic characteristics were compared in patients with and without evidence of cardiac involvement. Timing, type of cardiac involvement, disease activity, cardiovascular risk factors, and treatments were analyzed.
Among 312 patients with BS, 90 underwent cardiological assessment and 49 had confirmed cardiac involvement. Arrhythmias were the most frequent manifestation (n = 15), followed by pericarditis (n = 12) and ischemic heart disease (n = 8). Cardiac involvement occurred a median of 6.1 (2.5-8.7) years after BS diagnosis, although in a proportion of patients they preceded or coincided with diagnosis. Most patients had active systemic disease at the time of the cardiac involvement (93.9%), and were receiving immunosuppressant treatment (84%). Over 80% had at least one traditional cardiovascular risk factor, yet <40% were receiving cardiovascular primary prevention therapy before the first event. Male patients more frequently experienced ischemic manifestations, while arrhythmias were more common in females. No cardiac-related deaths were observed.
Cardiac involvement in BS is more common than traditionally reported when actively investigated. Cardiac involvement frequently occurs during active disease and in patients with a high burden of cardiovascular risk factors but suboptimal preventive therapy. These findings support the need for integrated cardio-rheumatologic management in BS.

PMID:
42391615
Bibliographic data and abstract were imported from PubMed on 03 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.